Pseudotumor Cerebri Syndrome Latest Advances

Automated Retinal Vascular Analysis Reveals Response to Acetazolamide in Idiopathic Intracranial Hypertension.

Journal: Translational vision science & technology

Published: December 04, 2025

Prognosticators of Optic Nerve Imaging in Malignant Pseudotumor Cerebri Syndrome: Erratum.

Journal: Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society

Published: December 01, 2025

Pilot analysis of Chitinase-3-like protein 1 and soluble Syndecan-1 CSF levels as potential biomarkers in relapsing-remitting multiple sclerosis.

Journal: Journal of neuroimmunology

Published: November 25, 2025

Surgical versus endovascular treatment for idiopathic intracranial hypertension.

Journal: Neuro-Chirurgie

Published: November 24, 2025

Idiopathic Intracranial Hypertension as the Initial Manifestation of Systemic Lupus Erythematosus: A Case Report and Literature Review.

Journal: The American journal of case reports

Published: November 23, 2025

Distinctive MRI findings and clinical correlations in pediatric idiopathic intracranial hypertension: optic nerve sheath dilatation and scleral flattening as diagnostic indicators.

Journal: Acta radiologica (Stockholm, Sweden : 1987)

Published: November 21, 2025

Correction: Novel insights into the pathophysiology of idiopathic intracranial hypertension: a commentary on brain volume and transverse sinus stenosis.

Journal: Journal of neurointerventional surgery

Published: November 18, 2025

Diagnosis, treatment and monitoring of idiopathic intracranial hypertension: Consensus recommendations of the Austrian IIH network (AN4IH).

Journal: Cephalalgia : an international journal of headache

Published: November 12, 2025

Re-calculated idiopathic intracranial hypertension prevalence rates with corrected age-filtering techniques.

Journal: Clinical neurology and neurosurgery

Published: November 09, 2025

Comment on "Surgical versus endovascular treatment for idiopathic intracranial hypertension".

Journal: Neuro-Chirurgie

Published: November 06, 2025

Stenting versus shunting in sight-threatening idiopathic intracranial hypertension: genuine equipoise.

Journal: Practical neurology

Published: November 05, 2025

Initial experience with the antithrombogenic-coated CARESTO stent for venous sinus stenting for idiopathic intracranial hypertension: A multicenter study.

Journal: Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences

Published: November 04, 2025

Filters

Automated Retinal Vascular Analysis Reveals Response to Acetazolamide in Idiopathic Intracranial Hypertension.

Automated Retinal Vascular Analysis Reveals Response to Acetazolamide in Idiopathic Intracranial Hypertension.

Prognosticators of Optic Nerve Imaging in Malignant Pseudotumor Cerebri Syndrome: Erratum.

Prognosticators of Optic Nerve Imaging in Malignant Pseudotumor Cerebri Syndrome: Erratum.

Pilot analysis of Chitinase-3-like protein 1 and soluble Syndecan-1 CSF levels as potential biomarkers in relapsing-remitting multiple sclerosis.

Pilot analysis of Chitinase-3-like protein 1 and soluble Syndecan-1 CSF levels as potential biomarkers in relapsing-remitting multiple sclerosis.

Surgical versus endovascular treatment for idiopathic intracranial hypertension.

Surgical versus endovascular treatment for idiopathic intracranial hypertension.

Idiopathic Intracranial Hypertension as the Initial Manifestation of Systemic Lupus Erythematosus: A Case Report and Literature Review.

Idiopathic Intracranial Hypertension as the Initial Manifestation of Systemic Lupus Erythematosus: A Case Report and Literature Review.

Distinctive MRI findings and clinical correlations in pediatric idiopathic intracranial hypertension: optic nerve sheath dilatation and scleral flattening as diagnostic indicators.

Distinctive MRI findings and clinical correlations in pediatric idiopathic intracranial hypertension: optic nerve sheath dilatation and scleral flattening as diagnostic indicators.

Correction: Novel insights into the pathophysiology of idiopathic intracranial hypertension: a commentary on brain volume and transverse sinus stenosis.

Correction: Novel insights into the pathophysiology of idiopathic intracranial hypertension: a commentary on brain volume and transverse sinus stenosis.

Diagnosis, treatment and monitoring of idiopathic intracranial hypertension: Consensus recommendations of the Austrian IIH network (AN4IH).

Diagnosis, treatment and monitoring of idiopathic intracranial hypertension: Consensus recommendations of the Austrian IIH network (AN4IH).

Re-calculated idiopathic intracranial hypertension prevalence rates with corrected age-filtering techniques.

Re-calculated idiopathic intracranial hypertension prevalence rates with corrected age-filtering techniques.

Comment on "Surgical versus endovascular treatment for idiopathic intracranial hypertension".

Comment on "Surgical versus endovascular treatment for idiopathic intracranial hypertension".

Stenting versus shunting in sight-threatening idiopathic intracranial hypertension: genuine equipoise.

Stenting versus shunting in sight-threatening idiopathic intracranial hypertension: genuine equipoise.

Initial experience with the antithrombogenic-coated CARESTO stent for venous sinus stenting for idiopathic intracranial hypertension: A multicenter study.

Initial experience with the antithrombogenic-coated CARESTO stent for venous sinus stenting for idiopathic intracranial hypertension: A multicenter study.